Carol Van Ryzin

1.4k total citations
22 papers, 761 citations indexed

About

Carol Van Ryzin is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Clinical Biochemistry. According to data from OpenAlex, Carol Van Ryzin has authored 22 papers receiving a total of 761 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 10 papers in Endocrinology, Diabetes and Metabolism and 6 papers in Clinical Biochemistry. Recurrent topics in Carol Van Ryzin's work include Sexual Differentiation and Disorders (12 papers), Hormonal and reproductive studies (6 papers) and Metabolism and Genetic Disorders (6 papers). Carol Van Ryzin is often cited by papers focused on Sexual Differentiation and Disorders (12 papers), Hormonal and reproductive studies (6 papers) and Metabolism and Genetic Disorders (6 papers). Carol Van Ryzin collaborates with scholars based in United States, Belgium and Italy. Carol Van Ryzin's co-authors include Deborah P. Merke, Gabriela P. Finkielstain, Reem Hanna, Ninet Sinaii, Nazli B. McDonnell, Wuyan Chen, Miki Nishitani, James C. Reynolds, Mimi S. Kim and Suvimol Hill and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Clinical Chemistry and Molecular Psychiatry.

In The Last Decade

Carol Van Ryzin

19 papers receiving 753 citations

Peers

Carol Van Ryzin
Carol Van Ryzin
Citations per year, relative to Carol Van Ryzin Carol Van Ryzin (= 1×) peers Guiomar Madureira

Countries citing papers authored by Carol Van Ryzin

Since Specialization
Citations

This map shows the geographic impact of Carol Van Ryzin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carol Van Ryzin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carol Van Ryzin more than expected).

Fields of papers citing papers by Carol Van Ryzin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carol Van Ryzin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carol Van Ryzin. The network helps show where Carol Van Ryzin may publish in the future.

Co-authorship network of co-authors of Carol Van Ryzin

This figure shows the co-authorship network connecting the top 25 collaborators of Carol Van Ryzin. A scholar is included among the top collaborators of Carol Van Ryzin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carol Van Ryzin. Carol Van Ryzin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Venditti, Charles P., Jennifer L. Sloan, Wadih M. Zein, et al.. (2025). O03: Hydroxocobalamin (OHCbl) dose intensification can prevent visual deterioration and improve neurological and biochemical outcomes in CBLC deficiency. Genetics in Medicine Open. 3. 101966–101966.
2.
Shchelochkov, Oleg A., Cristan Farmer, Colby Chlebowski, et al.. (2024). Intellectual disability and autism in propionic acidemia: a biomarker-behavioral investigation implicating dysregulated mitochondrial biology. Molecular Psychiatry. 29(4). 974–981. 4 indexed citations
3.
Liberton, Denise K., Konstantinia Almpani, Rashmi Mishra, et al.. (2024). Oral Health-Related Quality of Life in Rare Disorders of Congenital Facial Weakness. International Journal of Environmental Research and Public Health. 21(5). 615–615.
4.
Merke, Deborah P., Ashwini Mallappa, Margaret F. Keil, et al.. (2024). Adult Height Following Prepubertal Treatment With Antiandrogen, Aromatase Inhibitor, and Reduced Hydrocortisone in CAH. The Journal of Clinical Endocrinology & Metabolism. 110(7). e2171–e2182. 2 indexed citations
5.
Manoli, Irini, Susan Ferry, Carol Van Ryzin, et al.. (2023). Biomarkers to predict disease progression and therapeutic response in isolated methylmalonic acidemia. Journal of Inherited Metabolic Disease. 46(4). 554–572. 11 indexed citations
6.
Pangilinan, Faith, David Watkins, David J. Bernard, et al.. (2022). Probing the functional consequence and clinical relevance of CD320 p.E88del, a variant in the transcobalamin receptor gene. American Journal of Medical Genetics Part A. 188(4). 1124–1141. 5 indexed citations
7.
Shchelochkov, Oleg A., Irini Manoli, Paul Juneau, et al.. (2021). Severity modeling of propionic acidemia using clinical and laboratory biomarkers. Genetics in Medicine. 23(8). 1534–1542. 13 indexed citations
8.
Lehky, Tanya, Camilo Toro, Tianxia Wu, et al.. (2021). Differentiating Moebius syndrome and other congenital facial weakness disorders with electrodiagnostic studies. Muscle & Nerve. 63(4). 516–524. 4 indexed citations
9.
Shchelochkov, Oleg A., Irini Manoli, Jennifer L. Sloan, et al.. (2019). Chronic kidney disease in propionic acidemia. Genetics in Medicine. 21(12). 2830–2835. 23 indexed citations
10.
Brillante, Beth A, Lori C. Guthrie, & Carol Van Ryzin. (2015). McCune–Albright Syndrome: An Overview of Clinical Features. Journal of Pediatric Nursing. 30(5). 815–817. 6 indexed citations
11.
Mallappa, Ashwini, Ninet Sinaii, Parag Kumar, et al.. (2014). A Phase 2 Study of Chronocort, a Modified-Release Formulation of Hydrocortisone, in the Treatment of Adults With Classic Congenital Adrenal Hyperplasia. The Journal of Clinical Endocrinology & Metabolism. 100(3). 1137–1145. 106 indexed citations
12.
Ryzin, Carol Van. (2013). Adrenal Insufficiency: Causes and Prevention of Adrenal Crisis. Journal of Pediatric Nursing. 28(6). 620–621.
13.
Merke, Deborah P., Wuyan Chen, Rachel Morissette, et al.. (2013). Tenascin-X Haploinsufficiency Associated with Ehlers-Danlos Syndrome in Patients with Congenital Adrenal Hyperplasia. The Journal of Clinical Endocrinology & Metabolism. 98(2). E379–E387. 52 indexed citations
14.
Crocker, Melissa K., Corina Millo, Stephanie Beall, et al.. (2012). Use of PET/CT with Cosyntropin Stimulation to Identify and Localize Adrenal Rest Tissue following Adrenalectomy in a Woman with Congenital Adrenal Hyperplasia. The Journal of Clinical Endocrinology & Metabolism. 97(11). E2084–E2089. 32 indexed citations
15.
Chen, Wuyan, Xu Zhi, Miki Nishitani, et al.. (2012). Complement component 4 copy number variation and CYP21A2 genotype associations in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Human Genetics. 131(12). 1889–1894. 11 indexed citations
16.
Mueller, Sven C., Katherine Korelitz, Christina Carlisi, et al.. (2012). Incentive processing in Congenital Adrenal Hyperplasia (CAH): A reward-based antisaccade study. Psychoneuroendocrinology. 38(5). 716–721. 6 indexed citations
17.
Finkielstain, Gabriela P., Mimi S. Kim, Ninet Sinaii, et al.. (2012). Clinical Characteristics of a Cohort of 244 Patients with Congenital Adrenal Hyperplasia. The Journal of Clinical Endocrinology & Metabolism. 97(12). 4429–4438. 213 indexed citations
18.
Nandagopal, R., Ninet Sinaii, Nilo A. Avila, et al.. (2011). Phenotypic profiling of parents with cryptic nonclassic congenital adrenal hyperplasia: findings in 145 unrelated families. European Journal of Endocrinology. 164(6). 977–984. 51 indexed citations
19.
Finkielstain, Gabriela P., Wuyan Chen, Frank K. Fujimura, et al.. (2010). Comprehensive Genetic Analysis of 182 Unrelated Families with Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency. The Journal of Clinical Endocrinology & Metabolism. 96(1). E161–E172. 136 indexed citations
20.
Keil, Margaret F., et al.. (2008). Hypoglycemia During Acute Illness in Children With Classic Congenital Adrenal Hyperplasia. Journal of Pediatric Nursing. 25(1). 18–24. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026